GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acacia Pharma Group PLC (LTS:0PNT) » Definitions » Beta

Acacia Pharma Group (LTS:0PNT) Beta : N/A (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Acacia Pharma Group Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-05), Acacia Pharma Group's Beta is Not available.


Acacia Pharma Group Beta Historical Data

The historical data trend for Acacia Pharma Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acacia Pharma Group Beta Chart

Acacia Pharma Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Beta
Get a 7-Day Free Trial - - - - -

Acacia Pharma Group Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Acacia Pharma Group's Beta

For the Biotechnology subindustry, Acacia Pharma Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acacia Pharma Group's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acacia Pharma Group's Beta distribution charts can be found below:

* The bar in red indicates where Acacia Pharma Group's Beta falls into.



Acacia Pharma Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Acacia Pharma Group  (LTS:0PNT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Acacia Pharma Group Beta Related Terms

Thank you for viewing the detailed overview of Acacia Pharma Group's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Acacia Pharma Group (LTS:0PNT) Business Description

Traded in Other Exchanges
N/A
Address
Royston Road, The Officers’ Mess, Duxford, Cambridge, GBR, CB22 4QH
Acacia Pharma Group PLC is a biopharmaceutical company that focuses on developing and commercializing novel products to improve the care of patients undergoing medical treatments such as surgery, invasive procedures, or chemotherapy. Its product portfolio includes BARHEMSYS, BYFAVO, and APD403.

Acacia Pharma Group (LTS:0PNT) Headlines

No Headlines